Monday, 9 Nov 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US

NASDAQ: PGEN

  • #
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
  • Rare / orphan disease drugs
  • Auto-immune
  • Vaccine
  • Cell-therapy
  • Multi-specific antibodies
  • CVD
  • AstraZeneca
  • Hengrui Pharmaceuticals
  • Diabetes
  • SHA: 600276
XtalPi Partners with Pierre Fabre Laboratories – AI‑Powered Drug Discovery Alliance Targeting Novel Oncology Therapies
CompanyDeals

XtalPi Partners with Pierre Fabre Laboratories – AI‑Powered Drug Discovery Alliance Targeting Novel Oncology Therapies

XtalPi Inc. (HKG: 2228) and Pierre Fabre Laboratories announced a strategic partnership agreement to jointly launch multiple R&D projects in oncology aimed at discovering novel clinical drug candidates, with the…

November 9, 2026
Genoria and iCamuno Biotherapeutics Establish Joint Venture in Shanghai Free Trade Zone – Pioneering AI‑Driven Autologous Cell Therapy

Genoria and iCamuno Biotherapeutics Establish Joint Venture in Shanghai Free Trade Zone – Pioneering AI‑Driven Autologous Cell Therapy

November 9, 2026
Bayer Signs Strategic Agreements with ACITS and GHIC at CIIE – Building an Open Innovation Ecosystem in Urological Oncology

Bayer Signs Strategic Agreements with ACITS and GHIC at CIIE – Building an Open Innovation Ecosystem in Urological Oncology

November 9, 2026

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Precigen's RRP Therapy PRGN - 2012 Gets FDA Review
CompanyDrug

Precigen’s RRP Therapy PRGN-2012 Gets FDA Review

February 27, 2025
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up